Physician

Christine Ann Muglia-Chopra, M.D.

According to 2025 Medicare claims, Christine Muglia-Chopra, M.D. (NPI: 1588073159) practices allergy/immunology in the Newark, NJ market, with the plurality of this provider's patient population coming from Hunterdon, NJ. This provider's primary affiliated billing organization is HUNTERDON OTOLARYNGOLOGY ASSOCIATES (NPI: 1821181462; TIN: 222978497) and primary practice location at 08822-4946.

Muglia-Chopra's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 64 traditional Medicare patients, billed 1,452 HCPCS/CPT codes, and received $18,276 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 218 prescription claims across 68 beneficiaries totaling $41,016 in drug costs, led by Breo Ellipta (Fluticasone/Vilanterol). Open Payments data shows 30 records totaling $631. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $6,254 to $18,276. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	28	562	$6,254
2020	55	663	$7,969
2021	55	970	$16,083
2022	49	716	$16,153
2023	53	885	$13,332
2024	64	1,452	$18,276

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	19	35	$7,417
2019	64	226	$31,673
2020	48	165	$46,982
2021	51	148	$29,553
2022	51	189	$31,501
2023	54	175	$35,492
2024	68	218	$41,016

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	17	17	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	26	45	$97
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	18	18	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	24	27	$73
95004	Test for allergy using allergenic extract	15	706	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Breo Ellipta	Fluticasone/Vilanterol	25	870	$11,304
Dulera	Mometasone/Formoterol	19	570	$6,586
Epinephrine	Epinephrine	11	132	$2,613
Fluticasone Propionate	Fluticasone Propionate	42	2,916	$957
Ipratropium Bromide	Ipratropium Bromide	28	1,053	$744

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$631	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christine Ann Muglia-Chopra, M.D.?

Tedicare shows public-source Medicare data for Christine Ann Muglia-Chopra, M.D. (NPI 1588073159), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christine Ann Muglia-Chopra, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christine Ann Muglia-Chopra, M.D.?

Christine Ann Muglia-Chopra, M.D. is linked to HUNTERDON OTOLARYNGOLOGY ASSOCIATES (billing NPI 1821181462) in the available physician profile data.

Does Christine Ann Muglia-Chopra, M.D. have Open Payments data?

Christine Ann Muglia-Chopra, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.